Michael Belliveau of Wenham is a Partner at the Boston-based intellectual property law firm of Clark+Elbing LLP, representing clients at the forefront of scientific discovery and technological innovation. From universities, medical centers, and companies of all sizes to the investors who back them, Michael’s clients are leaders in their respective fields. Michael’s practice encompasses the areas of life science, chemistry, devices, and diagnostics. He advises clients pursuing inventions in various fields of biotechnology, including gene, cell, and mRNA therapies, cancer therapeutics and diagnostics, infectious disease therapeutics, and molecular diagnostics. Michae has a Ph.D. from Harvard University and a J.D. from Suffolk University Law School.